NPs Basic Information

Name
Arisugacin J
Molecular Formula C27H32O8
IUPAC Name*
(1S,2S,5R,7R,10R)-1,5,7-trihydroxy-14-(4-methoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-diene-3,16-dione
SMILES
C[C@@]12CC[C@@]3([C@@]([C@]1(CC4=C(O2)C=C(OC4=O)C5=CC=C(C=C5)OC)O)(C(=O)C[C@H](C3(C)C)O)C)O
InChI
InChI=1S/C27H32O8/c1-23(2)20(28)13-21(29)25(4)26(23,31)11-10-24(3)27(25,32)14-17-19(35-24)12-18(34-22(17)30)15-6-8-16(33-5)9-7-15/h6-9,12,20,28,31-32H,10-11,13-14H2,1-5H3/t20-,24-,25+,26-,27-/m1/s1
InChIKey
OQZMMSBLGYHONG-ZJQFWPFFSA-N
Synonyms
CHEMBL4440372; Arisugacin J; Arisugacin O; BDBM50530476
CAS NA
PubChem CID 102132271
ChEMBL ID CHEMBL4440372
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Naphthopyrans
        • Subclass: No Rank at Level Subclass
          • Direct Parent: Naphthopyrans

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 484.5 ALogp: 1.7
HBD: 3 HBA: 8
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 123.0 Aromatic Rings: 5
Heavy Atoms: 35 QED Weighted: 0.592

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.12 MDCK Permeability: 0.00001410
Pgp-inhibitor: 0.316 Pgp-substrate: 0.994
Human Intestinal Absorption (HIA): 0.216 20% Bioavailability (F20%): 0.831
30% Bioavailability (F30%): 0.897

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.801 Plasma Protein Binding (PPB): 82.06%
Volume Distribution (VD): 1.075 Fu: 12.22%

ADMET: Metabolism

CYP1A2-inhibitor: 0.735 CYP1A2-substrate: 0.934
CYP2C19-inhibitor: 0.809 CYP2C19-substrate: 0.645
CYP2C9-inhibitor: 0.808 CYP2C9-substrate: 0.257
CYP2D6-inhibitor: 0.082 CYP2D6-substrate: 0.428
CYP3A4-inhibitor: 0.809 CYP3A4-substrate: 0.794

ADMET: Excretion

Clearance (CL): 7.064 Half-life (T1/2): 0.104

ADMET: Toxicity

hERG Blockers: 0.103 Human Hepatotoxicity (H-HT): 0.705
Drug-inuced Liver Injury (DILI): 0.868 AMES Toxicity: 0.028
Rat Oral Acute Toxicity: 0.978 Maximum Recommended Daily Dose: 0.941
Skin Sensitization: 0.113 Carcinogencity: 0.962
Eye Corrosion: 0.003 Eye Irritation: 0.008
Respiratory Toxicity: 0.971
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003231 0.725 D06XZW 0.257
ENC002037 0.632 D0N0RU 0.250
ENC003130 0.573 D0P1UX 0.248
ENC000932 0.560 D04UTT 0.245
ENC002118 0.399 D09WKB 0.242
ENC002102 0.392 D06HBQ 0.238
ENC003423 0.388 D06GCK 0.233
ENC003422 0.388 D07MGA 0.228
ENC002412 0.368 D02DPU 0.228
ENC005020 0.365 D0Q0PR 0.223
*Note: the compound similarity was calculated by RDKIT.